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RIMARY tumors of the brainstem were once consid-
ered incurable lesions. With the description of dor-
sally exophytic tumors6 and the classification of
subtypes of brainstem gliomas,4,13 surgical approaches to
these difficult lesions were introduced. Investigators at
various centers have described their experience and com-
plications with these procedures.3–7,10,13
As experience in the surgical treatment of brainstem
tumors has increased, a number of pathological diagnoses
have been discovered, including pilocytic astrocytoma, fib-
rillary astrocytoma, ganglioglioma, primitive neuroecto-
dermal tumor, ependymoma, and gangliocytoma.2 When
the results of treatment are described, the different histo-
logical cell types are often grouped together, making diag-
nosis-specific counseling and treatment difficult. For this
reason, it was our intention to describe the treatment and
results at Primary Children’s Medical Center for the most
commonly encountered histological tumor type: JPA.
Clinical Material and Methods
Patients were identified by a search of our operative
database, tumor registry, and hospital discharge ICD-9
codes. The medical records of all patients with brainstem
tumors treated after 1980 were reviewed. Patients were
included if their tumor was centered in the brainstem and
was consistent with features of JPA on pathological exam-
ination. Patients were excluded if their tumor was report-
ed to be low-grade astrocytoma, fibrillary astrocytoma,
anaplastic astrocytoma, glioblastoma, or nonastrocytoma.
In addition, cases involving tectal plate gliomas, diffuse
pontine gliomas, and cerebellar tumors were excluded. All
cases involving pilocytic astrocytomas were reviewed and
reported by one neuropathologist who used current World
Health Organization classification.8 The medical records
and imaging studies were reviewed. The extent of resec-
tion was assessed by examining postoperative images
(Fig. 1). Resection was categorized as GTR if there was
no visible enhancement, linear enhancement in the resec-
tion cavity, or residual solid tumor. Disease progression
was defined as the appearance of recurrent tumor after
GTR or growth of residual tumor after partial resection on
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Object. In reports involving the operative treatment of brainstem tumors, multiple histological types are often
grouped together. To determine prognosis after resection, histology-specific data may be helpful.
Methods. Twenty-eight patients with juvenile pilocytic astrocytoma (JPA) of the brainstem (six in the midbrain, four
in the pons, and 18 in the medulla) were identified from the medical records. Initial treatment was resection in 25 and
biopsy sampling in three. Postoperative imaging revealed gross-total resection (GTR)  or resection with linear enhance-
ment (RLE) in 12 of 25 patients and solid residual tumor in the other 13. 
In 10 of the 13 patients harboring solid residual tumor, observation was undertaken; the residual lesion disappeared
in one, was stable in four, and progressed in five. Of the 12 patients with complete excision or RLE only, seven under-
went no further treatment, with tumor progression occurring in one. All patients were alive at last follow-up examina-
tion (range 0.3–20.4 years, mean 6 years). New neurological deficits commonly appeared immediately after resection
but often resolved. In six of the 28 patients, the new postoperative deficit was still present at last follow-up visit. The
5- and 10-year progression-free survival was 74 and 62%, respectively, after GTR or RLE and 19 and 19%, respec-
tively, when solid residual tumor was present.
Conclusions. Long-term survival after resection of JPAs of the brainstem has been observed and appears to be relat-
ed to the extent of initial excision.
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Abbreviations used in this paper: GTR = gross-total resection;
JPA = juvenile pilocytic astrocytoma; PFS = progression-free sur-
vival; RLE = resection with linear enhancement.
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follow-up imaging. Status was considered to be stable if
the tumor was demonstrated to be unchanged or smaller
on follow-up images.
In patients who underwent open resection, the approach
was individualized, but certain principles were followed.
The shortest route through tissue was chosen. If there was
an accessible tumor cyst, this was used as a corridor to
approach the tumor (Fig. 2 left). The brainstem was en-
tered through regions of distorted anatomy where the
tumor was bulging toward the surface and often causing
discoloration. When approaching intrinsic tumors in the
medulla and/or cervical cord, the route was through the
midline, but the superior limit of the midline incision in
the medulla was kept below the obex to reduce the risk to
the lower-region cranial nerves.3 Exophytic tumors (Fig. 2
right) were approached so that the exophytic portion was
encountered first. Tumor resection was performed by
entering the center of the lesion and gradually working
toward the margins by using an ultrasonic aspirator. Re-
section was terminated when the tissue color and texture
began to look normal. We did not attempt dissection out-
side the tumor at the tumor–brainstem interface.
Neurophysiological monitoring was used selectively,
including brainstem auditory evoked responses, somato-
sensory evoked potentials, electromyography of the sev-
enth and 11th cranial nerves, and, on one occasion, motor
evoked potentials. Adjuvant radio- and/or chemothera-
py were performed commonly in patients treated earlier 
in this series. As our experience evolved, these modalities




Between 1981 and 2002, a diagnosis of brainstem tu-
mor was established in 80 patients. In 52 cases the entry
criteria for the study were not met (29 diffuse pontine
gliomas, six tectal plate gliomas, six cerebellar astrocy-
tomas, three Grade II astrocytomas, one Grade III astro-
cytoma, two acoustic neuromas, two gangliogliomas, and
one oligodendroglioma). In two cases follow-up informa-
tion was inadequate. The remaining 28 patients with JPA
of the brainstem formed the basis of this study. There were
12 boys and 16 girls with a median age at presentation of
7.8 years (range 1.7–17.5 years).
Six tumors were located in the midbrain. The most
common midbrain location, seen in four patients, was the
cerebral peduncle (Fig. 3 left). The other two midbrain
lesions were located near the aqueduct. There were four
lesions in the pons, two in the cerebellar peduncle, and
two beneath the floor of the fourth ventricle (Fig. 3 right).
Eighteen of the tumors were in the medulla, 12 of which
were intrinsic or focal tumors within the medulla. Three
were dorsally exophytic with growth into the fourth ven-
tricle, and three were cervicomedullary lesions.
The most common clinical presentation was a focal
neurological deficit of cranial nerves and/or motor/senso-
ry long tracts, which occurred in 24 patients. The nature of
the deficit corresponded to the anatomical location of the
tumor. Six of the 24 patients with a focal deficit also had
hydrocephalus and one of them suffered seizures. Two
patients presented with hydrocephalus alone and two oth-
ers with headache alone. 
The treatment modalities are outlined in Fig. 4. The ini-
tial treatment in three patients involved acquiring a biopsy
sample. One patient harboring a midbrain lesion ventral to
the aqueduct underwent an open procedure through the
fourth ventricle. Adjuvant radiotherapy was performed and
the patient remained stable 6 months after diagnosis. In one
case a small lesion in the medulla near the eighth cranial
nerve nucleus was sampled. No adjuvant radio- or chemo-
therapy was undertaken, and the lesion has remained stable
for 3.3 years. In the third patient, a cerebral peduncle lesion
was sampled stereotactically. A shunt was placed to treat
hydrocephalus, and adjuvant radiotherapy was conducted.
The tumor progressed 26 months later, at which time the
patient underwent resection. Postoperative imaging re-
vealed linear enhancement in the tumor bed, and there was
no evidence of progression 9.5 years later.
Twenty-five of the 28 patients underwent resection as
initial treatment. In 12 postoperative imaging demonstrated
GTR or RLE in the tumor bed only. Seven of 12 patients
with GTR or RLE received no further treatment, and in one
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FIG. 1. A: Examples of resection classified as LE in the resec-
tion cavity. B: Examples of residual solid tumor.
local tumor progression occurred 1.1 years later. In none of
the other six was there evidence of JPA progression at fol-
low-up examination 0.8, 3.3, 6, 6.6, 10, and 15.7 years
later, respectively. In one of the patients in whom the JPA
did not progress, a primitive neuroectodermal tumor devel-
oped in the pineal region after 6.6 years. Neither radiother-
apy nor any other intervention had been performed. Four of
12 patients with GTR or RLE received radiotherapy (medi-
an dose 4750 cGy); progressive tumor growth was ob-
served in one patient at 0.63 years and  in the other three the
tumor was stable at 9, 16, and 20.4 years, respectively. One
patient with GTR or RLE was treated with adjuvant
chemotherapy (and no radiotherapy) but local tumor pro-
gression was documented at 0.42 years. 
In 13 of 25 patients who underwent open resection,
residual solid tumor was revealed on postoperative imag-
ing; in 10 of the 13 no adjuvant therapy was performed
and in five of the 10 the tumor progressed, in four it re-
mained stable, and in one progressive shrinkage of the
residual tumor occurred without adjuvant therapy (Fig. 5).
Two of 13 with residual solid tumor underwent radiother-
apy (median dose 5600 cGy), and in both further tumor
growth was documented 0.32 and 1.24 years postopera-
tively. One patient had undergone a biopsy procedure, ra-
diation treatment, and chemotherapy 10 years prior but
received no further adjuvant therapy after our resection;
the tumor size remained stable during the short follow-up
period (0.32 years).
All patients were alive at the last follow-up examination
(mean 5.8 years, range 0.3–20.4 years). In the entire study
population, PFS was 51% at 5 years and 44% at 10 years.
The rate was higher (74% at 5 years, 62% at 10 years)
when neuroimaging after the initial surgery revealed GTR
or RLE rather than residual solid tumor (19% at 5 and 10
years) (Fig. 6).
In 11 of the 28 patients recurrence or progression of their
JPA was demonstrated. At the time of recurrence, the man-
agement was radiotherapy alone in one patient and repeated
resection in 10 patients. Neuroimaging after the repeated
surgery revealed GTR or RLE in seven of 10 patients, with
stable tumor in six (at 1, 5, and 11 months, and 4.7, 9.5, and
9.7 years of follow up) and progressive tumor growth in one
(subsequently treated with chemotherapy). The other three
patients harbored residual solid tumor after repeated surgery
with two undergoing adjuvant radiotherapy. 
Surgery-related neurological complications were present
in the immediate postoperative period in 20 of 28 patients.
These complications resolved often; at last follow-up eval-
uation persistent deficits remained in six patients (Table 1).
These were observed in two of the 12 patients with GTR or
RLE, three of 13 patients with residual solid tumor, and one
of three patients in whom a biopsy sample was obtained.
Deficits were persistent in two of six patients in whom
surgery was performed in the midbrain, in one of four
patients in whom it was performed in the pons, and in three
of 18 patients in whom it was conducted in the medulla
(one of whom required a permanent tracheostomy). In the
three cases involving dorsally exophytic tumors, the
patients were free of complications at last follow up.
Discussion
Excluding diffuse pontine glioma, surgery has been
advocated for brainstem tumors. The multiple histological
types reported in many series prompted our review,
specifically of JPAs. In our experience with 28 JPAs of the
brainstem, excision (GTR or RLE) was associated with
the best chance of PFS at initial surgery and at the time of
recurrence. The role of adjuvant radio- and/or chemother-
apy was difficult to assess in this retrospective review, but
neither appeared to have a significant impact on disease
control.
Our results are similar to those reported by Pierre-Kahn,
et al.,10 who included benign and malignant lesions; how-
ever, within the classification “benign lesions” they found
a similar association between extent of resection and sur-
vival. Farmer and associates5 described 22 focal tumors of
the brainstem, including seven tectal lesions. The patho-
logical spectrum was mixed and included ganglioglioma,
JPA, fibrillary astrocytoma, and the tectal lesions, of which
tissue samples were not obtained for biopsy examination.
They compared two approaches of therapy. In the first rad-
ical surgery was performed in nine patients, in four of
whom the lesion progressed and was treated with radio-
therapy. In this group no new neurological symptoms re-
sulted from the treatment protocol. Seven other patients 
initially underwent radiotherapy, with four eventually un-
dergoing radical surgery at the time of tumor progression.
The neurological morbidity rate was considerably higher in
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FIG. 2. Left: A JPA of right middle cerebral peduncle. Cystic
component fills the fourth ventricle. The solid tumor was ap-
proached through the cyst. Right: Exophytic JPA of the left cere-
bral peduncle is approached via a transsylvian or subtemporal route
to enter through exophytic part of tumor.
FIG. 3. Left: Axial view of a JPA of the left cerebral peduncle.
Right: Sagittal view of a cystic JPA of the pons beneath the floor
of the fourth ventricle.
this group, with deficits occurring in five of seven patients.
The initial radiotherapy may have made the surgery more
difficult and contributed to the difference in morbidity rates
between these two approaches.
The association between brainstem tumor location and
pathological entity has been described previously. Khatib,
et al.,7 reported that of 12 dorsally exophytic brainstem
gliomas, 11 were JPAs. In this subgroup of patients the
prognosis was very good; the authors attributed this to the
histological type and the location, which allowed good
resection. Our experience was similar—the dorsally exo-
phytic JPAs were associated with the lowest resection-
related morbidity rate.
The neuroimaging-based distinction between GTR and
RLE did not appear to be of prognostic significance.
There were five patients with residual linear enhancement,
none of whom received adjuvant therapy. Tumor progres-
sion occurred in one of these patients, who also had neu-
rofibromatosis, at 1.1 years after surgery. In the other four
there were no signs of progression during follow-up peri-
ods of 3.7, 4.2, 5.9, and 17.5 years, respectively.
We observed tumor shrinkage after partial resection in
a patient in whom no other therapy was performed. This is
compatible with other reports. Schmandt and colleagues11
described a patient whose residual tumor regressed, grew,
and then regressed a second time, all without intervention.
They found 22 pediatric cases in the literature in which
low-grade tumors spontaneously regressed. Some of the
lesions were not confirmed histologically, but their review
included a JPA of the temporal/hypothalamic region and
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FIG. 4. Treatment pathway for this study population.
FIG. 5. Images demonstrating gradual regression of residual solid tumor without adjuvant radio- or chemotherapy.
four JPAs of the hypothalamic/chiasmatic area. There
were two cases in which pontine lesions regressed, one in
which a biopsy sample was not obtained and the other was
described as a Grade II fibrillary astrocytoma. Parsa, et
al.,9 identified 12 patients with optic pathway gliomas that
regressed spontaneously without therapy or many years
after therapy.
The role of surgery at the time of JPA recurrence has
been reviewed by Bowers and coworkers.1 Their report
included four brainstem lesions; in one case a GTR was
accomplished, but the tumor progressed 1.1 years later. In
the other three cases involving the brainstem, there was
significant residual tumor and disease progression at 0.3,
0.3 and 2.5 years after surgery, respectively. Our experi-
ence with repeated operation was favorable and was the
initial approach in 10 of 11 recurrences. In our population,
GTR or RLE was achieved in seven patients, in six of
whom the tumor has remained stable, without other thera-
py. The follow-up period was less than 1 year in three of
these patients, but in the other three cases tumor size was
stable at 4.7, 9.5, and 9.7 years, respectively.
Patients were not treated with stereotactic radiosurgery,
which has been reported in five pilocytic astrocytomas of
the brainstem that had progressed after surgery (three
cases), radiotherapy (one case), or biopsy sampling (one
case).12 A significant decrease in tumor size was revealed
on follow-up imaging in four patients; in one case the
tumor remains stable. None of the patients suffered neuro-
logical dysfunction related to radiosurgery. The follow-up
period for these patients was short and the role of focused-
beam irradiation is not yet clear. 
At present, our initial approach to residual disease is
observation. Postoperative imaging is performed at 3 and 6
months after surgery and then annually (in cases with or
without residual disease). Should the residual tumor pro-
gress, we have favored repeated operation. Stereotactic ra-
diosurgery may be an attractive option in the future if there
is evidence of its safety and efficacy.
Conclusions
At our center, JPA was the most common brainstem
tumor histology among the surgically treated cases, with a
preferential location in the medulla. Resection resulted in
long-term PFS but was associated with neurological mor-
bidity. The dysfunction apparent in the immediate postop-
erative phase improved but persisted in a significant por-
tion (six [21%] of 28) of patients. The PFS rate was high
for patients in whom a GTR or RLE was achieved. The
use of adjuvant radiotherapy was not associated with an
obviously longer PFS, regardless of the extent of the ini-
tial resection. At the time of recurrence, repeated resection
alone resulted in further PFS.
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